万丰奥威(002085) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥2,656,096,445.25, a decrease of 6.27% year-on-year[8]. - Net profit attributable to shareholders was ¥181,504,613.48, down 20.25% compared to the same period last year[8]. - Net profit attributable to shareholders after deducting non-recurring gains and losses was ¥118,095,209.98, a decrease of 43.95% year-on-year[8]. - Basic earnings per share for the reporting period was ¥0.08, down 20.00% compared to the same period last year[8]. - The weighted average return on net assets was 2.83%, a decrease of 1.02% compared to the previous year[8]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, decreased by 33.46% year-on-year, primarily due to the overall industry decline[26]. - The company reported a decrease in employee compensation payable to CNY 157,450,336.40 from CNY 175,711,721.80, a reduction of 10.06%[52]. - The net profit for the current period was ¥193,399,594.98, a decline of 19.24% from ¥239,302,663.46 in the previous period[69]. - The net profit attributable to the parent company was ¥601,934,335.60, a decrease of 23.2% compared to ¥784,538,225.04 in the previous period[83]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥13,965,691,691.52, an increase of 4.28% compared to the end of the previous year[8]. - Current assets totaled CNY 6,934,339,966.12 as of September 30, 2019, an increase of 3.04% from CNY 6,729,754,845.24 on December 31, 2018[46]. - Total liabilities amounted to CNY 7,380,648,991.01, up from CNY 6,553,761,777.19, indicating a growth of 12.59%[52]. - Total current liabilities were CNY 4,519,294,885.77, with no previous data provided for comparison[111]. - Total equity attributable to shareholders decreased to CNY 6,068,491,193.86 from CNY 6,330,544,402.36, a decline of 4.14%[55]. - Total liabilities were approximately $2.97 billion, with non-current liabilities accounting for about $666.68 million[121]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥874,218,242.00, an increase of 45.44%[8]. - Operating cash flow net increased by 45.44% year-on-year, mainly due to a reduction in cash payments related to operating activities[28]. - The company’s cash flow from investing activities decreased by 71.62% year-on-year, primarily due to reduced cash payments for fixed assets and other long-term assets[28]. - The company’s cash flow from financing activities decreased by 103.35% year-on-year, mainly due to increased cash payments for debt repayment and share buybacks[28]. - The net cash flow from operating activities was CNY 874,218,242.00, an increase of 45.4% compared to CNY 601,089,707.65 in the previous period[94]. - Cash inflow from operating activities totaled CNY 2,289,635,970.05, down from CNY 2,467,632,944.64 in the previous period[97]. Shareholder Information - The total number of shareholders at the end of the reporting period was 30,882[12]. - The largest shareholder, Wan Feng Auto Holding Group Co., Ltd., held 46.18% of the shares[12]. - The company repurchased a total of 39,989,130 shares, accounting for 1.83% of the total share capital, with a total transaction amount of RMB 295,240,496.09[31]. - The total amount allocated for the share repurchase plan was between RMB 30 million and RMB 60 million, with a maximum repurchase price of RMB 11 per share[31]. Government and Regulatory Compliance - The company received government subsidies amounting to ¥74,077,807.08 during the reporting period[8]. - There were no violations regarding external guarantees during the reporting period[39]. - The company did not engage in any non-operating fund occupation by controlling shareholders or their affiliates during the reporting period[40]. - The company did not conduct any entrusted financial management during the reporting period[41]. Research and Development - Research and development expenses were ¥90,716,185.85, down 13.67% from ¥105,063,600.04 in the previous period[66]. - Research and development expenses decreased to ¥31,101,140.84, down 19.7% from ¥38,781,034.85 in the previous period[73]. - The company reported a slight decrease in research and development expenses to ¥90,819,959.79, down from ¥94,499,502.90, indicating a focus on maintaining R&D investment[86]. Financial Standards and Reporting - The company has implemented new financial instrument standards, which may impact future financial reporting[121]. - The company has not undergone an audit for the third quarter report, which may affect the reliability of the financial data presented[122].